Anesthesia Techniques in Symptomatic Mandibular Molars With Irreversible Pulpitis
Anesthesia, Dental
About this trial
This is an interventional treatment trial for Anesthesia, Dental focused on measuring pain, irreversible pulpitis, intraligamentary injection, inferior alveolar nerve block
Eligibility Criteria
Inclusion Criteria: Systemically healthy patients The absence of periapical pathology Not sensitive to articaine or epinephrine No facial paresthesia Not taking any analgesic drug 6 hours before treatment Not taking any medication that interferes with anesthesia, such as tricyclic antidepressants and beta-blockers The absence of pathosis in areas planned for injection Not pregnant The absence of pathologic periodontal pockets during probing Patients with a mandibular first molar tooth exhibiting symptomatic irreversible pulpitis Exclusion Criteria: -
Sites / Locations
- Çukurova University, Faculty of Dentistry, Clinic of Endodontics
Arms of the Study
Arm 1
Arm 2
Active Comparator
Experimental
Inferior Alveolar Nerve Block Group
Intraligamentary Injection Group
A standard Inferior Alveolar Nerve Block (IANB) injection with a conventional dental injector and a 27-G needle to achieve pulpal anesthesia in mandibular molar teeth.
An intraligamentary injection that performed with a special pressure injection syringe (Sopira Citoject, Kulzer, Hanau, Germany) and a 30-G needle.